The Asia Pacific Tumor Ablation Market would witness market growth of 13.1% CAGR during the forecast period (2019-2025).
Technological innovations to enhance accuracy, portability, and cost-effectiveness are factors that enable market players to continuously improve and launch advanced products. Image-guided equipment and cryoablation are notable examples of these new technologies. The use of cooled radiofrequency denervation technology with internally cooled radiofrequency probes to increase the size of the lesion is one of the new technologies that is expected to play an important role in the expansion of the sector. This procedure allows complete denervation of the sacroiliac joint, which assists in the treatment of pain.
The microwave ablation technology is expected to experience an exponential market growth during the forecast period. Unlike electrical current in a radiofrequency ablation device, the energy of the microwave (MW) ablation device propagates electromagnet effect. This improves the use of microwave ablation technology in fabrics with low electrical conductivity such as bones and lungs.
The major benefits of this technology are the increased volume of tumor ablation, high-temperature stability, low ablation discomfort, and optimal cystic mass heating. Such advantages are expected to support the growth of this segment. In addition, the minimum duration of the procedure (5-10 minutes), improved efficacy with minimal complications and minimized hospital stay are projected to drive segment development.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Scope of the Study
- Surgical Ablation
- Laparoscopic Ablation and
- Percutaneous Ablation
- Radiofrequency Ablation
- Microwave Ablation
- Irreversible Electroporation and
- Other Technology
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer and
- Other Cancer
- South Korea
- Rest of Asia Pacific
- Medtronic PLC
- Johnson and Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Misonix, Inc.
- EDAP TMS S.A.
- Theraclion SA
- AngioDynamics, Inc.
- Mermaid Medical A/S
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- SonaCare Medical, LLC
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free